Sales growth changes of patented drugs in Canada 2022

Published by
Matej Mikulic,
Mar 26, 2024
This statistic displays the impacts on the annual sales growth of patented drugs which occurred during 2022. Exiting drug effects, loss of exclusivity, volume, and DAAs for Hepatitis C negatively impacted sales growth. The net change in sales during 2022 was an increase of 838 million Canadian dollars.

Patented drugs sales changes in Canada during 2022 (in million Canadian dollars)

Loading statistic...

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

February 2024

Region

Canada

Survey time period

2022

Supplementary notes

Red colored bars shows the negative impact on the annual sales growth.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Pharmaceutical industry in Norway "

The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Pharmaceutical industry in Norway

Overview

5

Pharmaceutical revenue

5

Production and trade

4

R&D, patents and new products

4

Further related statistics

9

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceutical industry in CanadaGlobal pharmaceutical industryPharmaceutical industry in the U.S.Top pharmaceutical drugsPharmaceutical research and development (R&D)
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.